Intermittent levosimendan for long-term management of severe cardiotoxicity induced by breast cancer chemotherapy – case series

20 June 2026 (09:54 - 10:03)
Organised by: Logo
Congress Presentation Part of: When cardiotoxicity strikes the heart: lessons from real cases Cardio-Oncology Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology